MedPath

Efficacy of Mydriatic Drops in Premature Infants

Completed
Conditions
Retinopathy of Prematurity
Registration Number
NCT03448640
Lead Sponsor
Bulent Ecevit University
Brief Summary

Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care unit. The investigators observed the pupil dilation effects and side effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop combination which the investigators routinely used in ROP examination.

Detailed Description

Purpose: To determine effect and vital change after topical application of phenylephrine 2.5% and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm infants.

Methods: Pupillary diameter, blood pressure, pulse rate, and oxygen saturation were monitored before, and after up to 24 hours 60 ROP screening examinations.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Infants who were first ROP examinations
  • infants born before 32 weeks.
Exclusion Criteria
  • Developmental ocular and/or systemic anomalies.
  • Drug use that can affect vital values
  • Unstable general condition
  • Food intolerance
  • Recurrent vomiting.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The mean pupillary diameteran average of 1 year

will be measured with a ruler after 60 minutes instillation of mydriatic

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath